E. Galmozzi

3.2k citations

45 papers · 2.5k indexed · 1 hit paper · h-index 21

Impact in

Hepatology top 1%
- Hepatitis C virus research
- Liver Disease and Transplantation
Epidemiology top 2%
- Liver Disease Diagnosis and Treatment
- Hepatitis B Virus Studies

Papers in

Hepatology 28
- Hepatitis C virus research 27
Epidemiology 27
- Liver Disease Diagnosis and Treatment 20
- Hepatitis B Virus Studies 17

Co-authors: Luca Valenti Paola Dongiovanni Silvia Fargion Anna Ludovica Fracanzani F. Facchetti Raffaela Rametta Valério Nobili Marco Maggioni
Journals: Journal of Hepatology (8 papers)Digestive and Liver Disease (6 papers)Hepatology (5 papers)Journal of Viral Hepatitis (3 papers)Journal of Cellular Physiology (2 papers)
Partner nations: Italy United States Australia

In The Last Decade

E. Galmozzi

44 papers receiving 2.4k citations

Hit Papers

align trajectories log scale

Homozygosity for the patatin‐like phospholipase‐3/adiponutrin I148M polymorphism influences liver fibrosis in patients with nonalcoholic fatty liver disease† 2010 · 497 citations

Peers

Countries citing papers authored by E. Galmozzi

Since Specialization

Citations

This map shows the geographic impact of E. Galmozzi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Galmozzi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Galmozzi more than expected).

Fields of papers citing papers by E. Galmozzi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E. Galmozzi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Galmozzi. The network helps show where E. Galmozzi may publish in the future.

Co-authors

The 25 scholars most cited alongside E. Galmozzi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with E. Galmozzi Line = papers co-authored together E. Galmozzi links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	The CCR5 and CXCR3 Pathways in Hepatitis C Virus Liver Transplanted Recipients Treated by a Direct Antiviral Agent Regimen: Informative Kinetics Profiles Viral Immunology ·Giuseppe Colucci, Federica Invernizzi, Sara Uceda Renteria, Riccardo Perbellini, Elisabetta Degasperi, Roberta D’Ambrosio, E. Galmozzi, G. Lunghi, 中田智康, Pietro Lampertico, Maria Francesca Donato	2021	3
2	Clinical but not genetic variables predict the development of hepatocellular carcinoma in hepatitis C cirrhotic patients treated with direct acting antivirals: a 3-year study in 509 patients Digestive and Liver Disease ·Elisabetta Degasperi, E. Galmozzi, F. Facchetti, Roberta D’Ambrosio, R. Soffredini, Marta Borghi, Riccardo Perbellini, Massimo Iavarone, Angelo Sangiovanni, Pietro Lampertico	2019	1
3	Chemokine Receptor 5 Has No Major Role in the Severity of Hepatitis C Virus-Related Liver Damage Viral Immunology ·Giuseppe Colucci, Roberta D’Ambrosio, E. Galmozzi, Marco Maggioni, Stella De Nicola, Alessio Aghemo, Massimo Colombo	2018	1
4	Hepatitis delta virus and hepatocellular carcinoma: an update Epidemiology and Infection ·R. Romeo, Arnolfo Petruzziello, Eve‐Isabelle Pécheur, F. Facchetti, Riccardo Perbellini, E. Galmozzi, Najeeb Ullah Khan, Javier Berdugo Pérez, R. Sarisorkhabi, Gerardo Botti, Giovanna Loquercio	2018	34
5	Tenofovir alafenamide as a rescue therapy in a patient with HBV-cirrhosis with a history of Fanconi syndrome and multidrug resistance Journal of Hepatology ·G. Grossi, Alessandro Loglio, F. Facchetti, Marta Borghi, R. Soffredini, E. Galmozzi, G. Lunghi, Anuj Gaggar, Pietro Lampertico	2017	21
6	Intrahepatic innate immune response pathways are downregulated in untreated chronic hepatitis B Journal of Hepatology ·Fanny Lebossé, Barbara Testoni, Judith Fresquet, F. Facchetti, E. Galmozzi, Dalton M. Reed, Valérie Hervieu, Pascale Berthillon, Françoise Berby, Isabelle Bordes, David Durantel, Massimo Levrero, Pietro Lampertico, Fabien Zoulim	2016	122
7	High-resolution melting assay for genotyping of IFNL4-associated dinucleotide variant rs368234815 Clinical Microbiology and Infection ·E. Galmozzi, F. Facchetti, Riccardo Perbellini, Alessio Aghemo	2014	3
8	Limited Utility of ITPA Deficiency to Predict Early Anemia in HCV Patients with Advanced Fibrosis Receiving Telaprevir PLoS ONE ·Alessio Aghemo, Eleonora Grassi, Maria Grazia Rumi, Roberta D’Ambrosio, E. Galmozzi, Elisabetta Degasperi, Davide Castaldi, R. Soffredini, Massimo Colombo	2014	17
9	Eukaryotic initiation factor 5B: A new player for the anti-hepatitis C virus effect of ribavirin? Medical Hypotheses ·E. Galmozzi, Alessio Aghemo, Massimo Colombo	2012	5
10	Allelic inhibition of displacement activity: A simplified one tube allele-specific PCR for evaluation of ITPA polymorphisms Journal of Virological Methods ·E. Galmozzi, F. Facchetti, Elisabetta Degasperi, Alessio Aghemo, Pietro Lampertico	2012	3
11	Interleukin 28B Polymorphism Predicts Pegylated Interferon Plus Ribavirin Treatment Outcome in Chronic Hepatitis C Genotype 4 Hepatology ·Stella De Nicola, Alessio Aghemo, Maria Grazia Rumi, E. Galmozzi, Luca Valenti, R. Soffredini, Raffaele De Francesco, Gian Maria Prati, Roberta D’Ambrosio, Cristina Cheroni, Maria Francesca Donato, Massimo Colombo	2011	67
12	I148M Patatin-Like Phospholipase Domain-Containing 3 Gene Variant and Severity of Pediatric Nonalcoholic Fatty Liver Disease Hepatology ·Luca Valenti, Anna Alisi, E. Galmozzi, Andrea Bartuli, Fuentealba Mauricio, Arianna Alterio, Paola Dongiovanni, Silvia Fargion, Valério Nobili	2010	215
13	A tetra-primer amplification refractory mutation system polymerase chain reaction for the evaluation of rs12979860 IL28B genotype Journal of Viral Hepatitis ·E. Galmozzi, Fuentealba Mauricio, Raffaela Rametta, Paola Dongiovanni, Anna Ludovica Fracanzani, Qingfeng Wei, Washington José de Sousa, B D Matthews, Silvia Fargion, Luca Valenti	2010	25
14	Beta-globin mutations are associated with parenchymal siderosis and fibrosis in patients with non-alcoholic fatty liver disease Journal of Hepatology ·Luca Valenti, Elena Canavesi, E. Galmozzi, Paola Dongiovanni, Raffaela Rametta, B D Matthews, Marco Maggioni, Anna Ludovica Fracanzani, Silvia Fargion	2010	49
15	Patatin-Like Phospholipase Domain-Containing 3 I148M Polymorphism, Steatosis, and Liver Damage in Chronic Hepatitis C σ Hepatology ·Luca Valenti, Maria Grazia Rumi, E. Galmozzi, Alessio Aghemo, Fuentealba Mauricio, Stella De Nicola, Paola Dongiovanni, Marco Maggioni, Anna Ludovica Fracanzani, Raffaela Rametta, Massimo Colombo, Silvia Fargion	2010	193
16	HFE Genotype, Parenchymal Iron Accumulation, and Liver Fibrosis in Patients With Nonalcoholic Fatty Liver Disease Gastroenterology ·Luca Valenti, Anna Ludovica Fracanzani, Elisabetta Bugianesi, Paola Dongiovanni, E. Galmozzi, Ester Vanni, Elena Canavesi, Ezio Lattuada, Giancarlo Roviaro, Giulio Marchesini, Silvia Fargion	2009	220
17	Melanoma contains CD133 and ABCG2 positive cells with enhanced tumourigenic potential European Journal of Cancer ·Elena Monzani, F. Facchetti, E. Galmozzi, E. Corsini, Anna Benetti, Chiara Cavazzin, Angela Gritti, A. Piccinini, Danilo Porro, Mario Santinami, Gloria Invernici, Eugenio Parati, Giulio Alessandri, Caterina A. M. La Porta	2007	442
18	Increased levels of the CD40:CD40 ligand dyad in the cerebrospinal fluid of rats with vitamin B12(cobalamin)-deficient central neuropathy Journal of Neuroimmunology ·Daniela Veber, Elena Mutti, E. Galmozzi, Sabrina Martins Lage Cedrola, Stefania Galbiati, Alberto Morabito, G Tredici, Caterina A. M. La Porta, Giuseppe Scalabrino	2006	16
19	Expression of Concern: HER2 signaling enhances 5′UTR‐mediated translation of c‐Myc mRNA Journal of Cellular Physiology ·E. Galmozzi, Patrizia Casalini, Marilena V. Iorio, R. J. Yang, Soumia Otmani, Sylvie Ménard	2004	28
20	Exon 3 of the α folate receptor gene contains a 5′ splice site which confers enhanced ovarian carcinoma specific expression FEBS Letters ·E. Galmozzi, Antonella Tomassetti, Sabrina Sforzini, A. THORPE, E. APOSTOLEANO, Natalia Białoń, Patrick C. Elwood, Silvana Canevari	2001	9

About E. Galmozzi

E. Galmozzi is a scholar working on Hepatology, Epidemiology, Rheumatology, Immunology and Allergy and Infectious Diseases, having authored 45 papers that have together received 2.5k indexed citations. Recurring topics across this work include Hepatitis C virus research (27 papers), Liver Disease Diagnosis and Treatment (20 papers), Hepatitis B Virus Studies (17 papers), RNA modifications and cancer (4 papers), RNA Research and Splicing (4 papers), Biochemical and Molecular Research (3 papers), Diet, Metabolism, and Disease (3 papers) and Monoclonal and Polyclonal Antibodies Research (3 papers). The work is most often cited by research in Hepatology (829 citations), Epidemiology (1.5k citations), Endocrinology, Diabetes and Metabolism (514 citations), Oncology (547 citations) and Cell Biology (322 citations). E. Galmozzi has collaborated with scholars based in Italy, United States and Australia. Frequent co-authors include Luca Valenti, Paola Dongiovanni, Silvia Fargion, Anna Ludovica Fracanzani, F. Facchetti, Raffaela Rametta, Valério Nobili, Marco Maggioni, Giancarlo Roviaro and Elisabetta Bugianesi. Their work appears in journals such as Journal of Hepatology, Digestive and Liver Disease, Hepatology, Journal of Viral Hepatitis and Journal of Cellular Physiology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact